Glucosamine and chondroitin have mixed evidence, and the honest answer is that they probably don’t work for most people with osteoarthritis. A combined analysis of 29 studies with over 6,000 participants found that each supplement taken separately reduced pain, but the combination of the two did not. The American College of Rheumatology strongly recommends against using glucosamine and chondroitin for osteoarthritis of the hand, hip, or knee. That said, certain subgroups of patients may benefit, and the supplements are generally safe, which is why they remain popular.
What These Supplements Actually Do in Your Joints
Glucosamine and chondroitin are natural building blocks of cartilage and the fluid that lubricates your joints. Glucosamine is an amino sugar your body uses to produce the structural molecules that give cartilage its firmness and elasticity. It’s actually a bottleneck in that production process, meaning the speed at which your body makes glucosamine limits how fast it can build new cartilage.
The theory behind supplementation is straightforward: supply more raw materials and your joints can repair themselves better. In lab studies, these compounds work through two pathways. They stimulate the production of new cartilage tissue, and they reduce inflammation that breaks cartilage down. That dual action sounds promising on paper, but the real question is whether swallowing a pill delivers enough of these compounds to your joints to make a measurable difference.
What the Largest Trials Found
The most important piece of evidence is the NIH-funded GAIT trial, one of the largest and most rigorous studies ever conducted on these supplements. For the overall group of participants with knee osteoarthritis, glucosamine and chondroitin performed no better than placebo. But there was one notable exception: among people with moderate to severe knee pain, the combination provided real relief. About 79% of that subgroup experienced at least a 20% reduction in pain, compared to 54% on placebo.
That subgroup finding has fueled debate for years. It suggests the supplements may help people with worse symptoms while doing little for those with mild pain. However, subgroup analyses are statistically less reliable than overall trial results, so many researchers treat this finding with caution rather than enthusiasm.
A separate trial published in The Journal of Family Practice painted a less optimistic picture. At six months, patients taking the combination actually had less pain reduction than the placebo group (a 12-point drop versus a 20-point drop on a 100-point scale). That trial also found more adverse events in the supplement group. This kind of contradictory result is common in glucosamine research, which is part of why guidelines have moved against recommending it.
Can They Slow Cartilage Loss?
Beyond pain relief, some people take these supplements hoping to slow the physical breakdown of their joints. The evidence here is also split. Two large two-year trials looked at whether glucosamine and chondroitin could prevent cartilage from thinning in the knee, measured by the narrowing of space between bones on an X-ray.
An Australian study with 605 participants found that the combination of glucosamine sulfate and chondroitin did slow joint space narrowing over two years. Neither supplement alone had that effect. A U.S. study with 572 participants, however, found no difference in joint space between any supplement group and placebo. Notably, the Australian study used glucosamine sulfate while the U.S. study used glucosamine hydrochloride, a distinction that may matter (more on that below).
Two additional two-year studies of chondroitin alone, involving roughly 900 participants combined, both found that chondroitin slowed joint space narrowing compared to placebo. This suggests chondroitin on its own may have structural benefits, even if the pain relief evidence is inconsistent.
Why Professional Guidelines Recommend Against Them
The American College of Rheumatology and Arthritis Foundation jointly issued guidelines that strongly recommend against glucosamine and chondroitin for hand, hip, and knee osteoarthritis. That’s their strongest level of discouragement.
This doesn’t mean the supplements are dangerous. It means that when you look at the full body of evidence rather than cherry-picking favorable studies, the overall picture doesn’t support a reliable benefit. The positive results from individual trials haven’t been consistent enough across different research groups to meet the bar these organizations set for a treatment recommendation. For the average person with osteoarthritis, the expected benefit is too small and too uncertain to endorse.
The Glucosamine Sulfate vs. Hydrochloride Question
Not all glucosamine supplements are the same. Most clinical trials showing positive results used glucosamine sulfate, while several of the negative trials, including the U.S. arm of the GAIT study, used glucosamine hydrochloride. Some researchers believe the sulfate form is more effective, possibly because the sulfate component itself plays a role in cartilage metabolism. If you decide to try glucosamine, the sulfate form has the stronger track record in clinical research.
Standard Dosing Used in Research
Across more than 100 studies, the most commonly tested doses were 1,500 mg of glucosamine and 1,200 mg of chondroitin per day, typically split into two or three doses. These are the amounts used in the major trials, so if you’re comparing supplement labels to research evidence, those are the numbers to look for. Many commercial products use lower doses or different forms, which makes it hard to generalize trial results to every bottle on the shelf.
Safety and Side Effects
Glucosamine and chondroitin have a good safety profile overall. Side effects tend to be mild, mostly gastrointestinal discomfort like nausea or bloating.
One long-standing concern has been whether glucosamine affects blood sugar, since animal studies using extremely high intravenous doses (100 to 200 times the human oral dose) caused insulin resistance. This hasn’t held up in human research. A randomized trial of healthy adults taking 1,500 mg of glucosamine sulfate daily for 12 weeks found no changes in fasting blood sugar or insulin levels. For people whose diabetes is already well-controlled, the standard dose does not appear to disrupt blood sugar management. There is some preliminary evidence that glucosamine could worsen glucose tolerance in people with undiagnosed or untreated diabetes, so that’s worth knowing if you’re in a gray area with blood sugar.
Who Might Still Want to Try Them
Despite the tepid overall evidence, there are reasons some people choose to take these supplements. If you have moderate to severe knee pain and haven’t responded well to other treatments, the GAIT trial subgroup data suggests a possible benefit worth testing for yourself. The supplements are inexpensive relative to many alternatives, and the risk of harm is low.
The practical approach, if you decide to try them, is to use glucosamine sulfate at 1,500 mg and chondroitin at 1,200 mg daily, give it at least two to three months to assess whether your symptoms improve, and stop if you don’t notice a difference. Many of the major trials measured outcomes at 12 and 24 weeks, so you shouldn’t expect rapid results. If nothing has changed after three months of consistent use, the supplements are unlikely to help you.